Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2015
The purpose of this study is to determine whether the HBAI20 vaccine is safe and more immunogenic than the HBVaxPro-10µg in people who have never been vaccinated with a hepatitis B vaccine and in people who have been vaccinated 6 times with hepatitis B vaccine but do not have a protective anti hepatitis B antibody titer.
Epistemonikos ID: 70d437092db98b99ffacf8a503297a8adae96470
First added on: Nov 24, 2021